Shopping Cart
- Remove All
- Your shopping cart is currently empty
YG1702, a potent inhibitor specific to ALDH18A1, suppresses the proliferation of MYCN-amplified neuroblastoma (NB) and reduces MYCN expression. This compound exhibits high-affinity physical interaction with ALDH18A1, which may influence its enzymatic activity [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | Inquiry | 8-10 weeks | |
50 mg | Inquiry | 8-10 weeks |
Description | YG1702, a potent inhibitor specific to ALDH18A1, suppresses the proliferation of MYCN-amplified neuroblastoma (NB) and reduces MYCN expression. This compound exhibits high-affinity physical interaction with ALDH18A1, which may influence its enzymatic activity [1]. |
In vivo | YG1702, administered intraperitoneally at a dosage of 45 mg/kg every three days for a total of three administrations, inhibited the growth of xenografts in tumor-bearing mice [1]. |
Molecular Weight | 478.56 |
Formula | C23H30N2O7S |
Cas No. | 724737-08-0 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.